Amylin Pharmaceuticals Inc. (AMLN) said Monday that its diabetes drug Byetta doesn't share a connection to thyroid cancer risk seen in potential competitor, Novo Nordisk A/S's (NVO) Liraglutide...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0.006 | 0.009 | 0.003 | 1082408 | 0.00536164 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.